US2021369737A1PendingUtilityA1

Prostate function support formula

69
Assignee: INNOVUS PHARMACEUTICALS INCPriority: Dec 1, 2017Filed: Aug 13, 2021Published: Dec 2, 2021
Est. expiryDec 1, 2037(~11.4 yrs left)· nominal 20-yr term from priority
Inventors:Bassam Damaj
A61K 36/185A61K 9/2095A61K 36/736A61P 13/08A61K 31/01A61K 31/4415A61K 33/30A61K 36/82A61K 31/375A61K 31/198A61P 13/10A61K 9/2013A61K 31/575A61K 31/191A61K 31/355A61K 36/889A61K 33/04A61K 33/34A61K 9/2054
69
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides unit dosage forms and methods that are effective to improve prostate function. Such unit dosage forms and methods are useful to decrease bladder discomfort and improve urinary flow in men.

Claims

exact text as granted — not AI-modified
1 - 8 . (canceled) 
     
     
         9 . A method to improve prostate function, comprising administering a composition comprising:
 saw palmetto;   beta-sitosterol; and   stinging nettle,   wherein the composition is provided in a capsule dosage form.   
     
     
         10 . The method of  claim 9 , wherein the composition comprises about 300 mg saw palmetto. 
     
     
         11 . The method of  claim 10 , wherein the saw palmetto is a 40-45% extract. 
     
     
         12 . The method of  claim 11 , wherein the composition further comprises gelatin, magnesium stearate and/or silicon dioxide. 
     
     
         13 . The method of  claim 12 , wherein the composition further comprises gelatin, magnesium stearate, and silicon dioxide. 
     
     
         14 . The method of  claim 13 , wherein the composition further comprises pumpkin seed powder. 
     
     
         15 . The method of  claim 9 , wherein the capsule is administered orally. 
     
     
         16 . The method of  claim 9 , wherein the method also decreases bladder discomfort and/or improves urinary flow. 
     
     
         17 . A method to decrease bladder discomfort, comprising orally administering a composition comprising:
 saw palmetto;   beta-sitosterol;   stinging nettle;   gelatin;   magnesium stearate; and   silicon dioxide,   wherein the composition is provided in a capsule dosage form.   
     
     
         18 . The method of  claim 17 , wherein the composition comprises about 300 mg saw palmetto. 
     
     
         19 . The method of  claim 18 , wherein the saw palmetto is a 40-45% extract. 
     
     
         20 . The method of  claim 19 , wherein the composition further comprises pumpkin seed powder. 
     
     
         21 . The method of  claim 17 , wherein the method also improves urinary flow. 
     
     
         22 . A method to improve urinary flow, comprising orally administering a composition comprising:
 saw palmetto;   beta-sitosterol;   stinging nettle;   gelatin;   magnesium stearate; and   silicon dioxide, and   wherein the composition is provided in a capsule dosage form.   
     
     
         23 . The method of  claim 22 , wherein the composition comprises about 300 mg saw palmetto. 
     
     
         24 . The method of  claim 23 , wherein the saw palmetto is a 40-45% extract. 
     
     
         25 . The method of  claim 24 , wherein the composition further comprises pumpkin seed powder. 
     
     
         26 . The method of  claim 22 , wherein the method also decreases bladder discomfort.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.